Centenes first-quarter Superior and Services Revenues up 12.

Centene’s first-quarter Superior and Services Revenues up 12.5 percent to $1 treatment of impotence .022 billion Centene Corporation today announced its financial outcomes for the quarter ended March 31, 2010. First Quarter Highlights Quarter-end managed care at-risk membership of just one 1,468,600, an increase of 221,300 users year over year.High quality and Program Revenues of $1.022 billion, representing 12.5 percent year over year growth.HEALTH ADVANTAGES Ratio of 84.0 percent.3 percent.Days in statements payable of 47.7, including pharmacy claims payable.Diluted income per share from continuing procedures of $0.41.75 million shares of common stock, including the underwriters’ overallotment option, for a open public offering price of $19.25 per share.6 million.02 to $0.03 in 2010 2010.In March 2010, we completed the previously declared sale of our New Jersey health plan, University Health Plans, and recorded a pre-tax gain on sale of $8.2 million, or $0.08 per diluted share, in discontinued operations through the first quarter of 2010.


Submitted comments were reviewed by DSM-5 Work Groups and resulted in additional refinement of the requirements. The field trial outcomes can help further refine the requirements and provide invaluable information for DSM-5, to be released in May 2013.. Center for Mental and Addiction Wellness selected as field trial sites for DSM-5 criteria Toronto’s Center for Addiction and Mental Health provides been selected as one of seven adult field trial sites in North America and the just site in Canada to check proposed diagnostic criteria for the American Psychiatric Association’s fifth edition of the Diagnostic and Statistical Manual of Mental Disorders .

Other articles from category "allergy":

Random articles